Harbour BioMed and Viva Biotech declare key coordinated effort to promote biotech new startups Kumar Jeetendra | August 1, 2020 HBM will combine its top Harbour Mice® stage H2L2 and its expertise in global research and development of innovative molecules, with Viva Biotech’s structure-based early phase drug discovery services. This complementary partnership will provide advanced biotech startups access to next generation technologies that create synergies to accelerate the route between ideation to merchandise. The incubated …
The Native Antigen Company declares custom agreement administration to create flu An and B antigens Kumar Jeetendra | August 23, 2020 The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), among the world’s leading suppliers of reagents which enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the debut of its custom contract agency to rapidly develop antigen panels for influenza A and B viruses. This new service provides …
